Immune sabotage: How a Vitamin A byproduct compromises the body’s normal anti-cancer response
by Ludwig Cancer Research edited by Lisa Lock, reviewed by Robert Egan Editors’ notes Credit: iScience (2025). DOI: 10.1016/j.isci.2025.113675 Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by which a metabolic derivative of vitamin A—all-trans retinoic acid—compromises both the body’s normal anti-cancer immune response and, in a different context, the efficacy […]
